Genetix Launches Second Generation ClonePix System
Complete the form below to unlock access to ALL audio articles.
Genetix has announced the launch of the new ClonePix™2 system - the second generation system based on the company’s well-established and successful technology and chemistries for clone screening and selection. The ClonePix 2 system utilizes fluorescence and white light imaging and advanced image analysis capabilities to automatically screen more clones in less time, select cells with optimal expression levels and pick colonies with accuracy and confidence.
The original ClonePix FL systems are used in over one hundred biopharmaceutical organizations and research laboratories to provide faster, more productive workflows than conventional techniques. Often employed to reduce cell line/antibody development times, data from these systems are cited increasingly in scientific literature and at conferences, an indication of acceptance within the industry.
The most frequently applied approach to monitor expression levels takes advantage of specific chemistries developed by Genetix to enable label-free quantification of secreted proteins – a significant advantage when screening and selecting cell lines for production of biotherapeutics, such as monoclonal antibodies.
Dr. Mark Truesdale, Marketing Manager at Genetix, explained the reasoning behind the development of a second generation instrument: “Working closely with our existing customers has enabled us to specify software and hardware enhancements to raise overall performance. Imaging analysis software has been enhanced to improve consistency when ranking clones. A redesign of robotics has reduced the number of plate handling steps, thereby minimizing the risk of colony disturbance or contamination and giving greater picking accuracy. We believe that ClonePix 2 users will experience a smoother, more efficient workflow.”